ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001307.1|Chaxapeptin_2 # 630 # 764 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.615	BGC0001307.1|Chaxapeptin_2 	630	764	+	Loose	900	21.9422	adeH	33.33	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAACCCCAGATGACTGAGCTTCAGCCGGAGGCCTACGAGGCGCCGTCCCTCATCGAGGTGGGCGAGTTCTCGGAGGACACGCTCGGCTTCGGAAGCAAGCCGCTGGACAGCTTCGGCCTGAACTTCTTTTAG	MEPQMTELQPEAYEAPSLIEVGEFSEDTLGFGSKPLDSFGLNFF	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	9.11	gnl|BL_ORD_ID|493|hsp_num:0	542			972	1062	tetracycline
BGC0001307.1|Chaxapeptin_4 # 2570 # 2827 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.620	BGC0001307.1|Chaxapeptin_4 	2570	2827	+	Loose	500	25.409	LCR-1	48.0	3002997	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	LCR beta-lactamase	ATGCGCCTGCACCCTGATATCGTCATCGCGGAAACCGAAGACGGTGCGGTCCTACTACACCAAAGGACCGGCCGCTACTGGCAGCTGAACACCACGGGCATGGCGGTCATCGAAAGCCTGACTTCCGGTGAGACCCTCGCCGAGATCACGCACCGTATGGCCAAGCGTTACGGCTTGCCCGCTGAGCAGGTCCGGCAGGACGTCGAAGCCGTCGTCCATCAACTACACGCGGCCCAGATAGTGGAGAGCACCTCGTGA	MRLHPDIVIAETEDGAVLLHQRTGRYWQLNTTGMAVIESLTSGETLAEITHRMAKRYGLPAEQVRQDVEAVVHQLHAAQIVESTS	MLKSTLLAFGLFIALSARAENQAIAKLFLRAGVDGTIVIESLTTGQRLVHNDPRAQQRYPAASTFKVLNTLIALEEGAISGENQIFHWNGTQYSIANWNQDQTLDSAFKVSCVWCYQQIALRVGALKYPAYIQQTNYGHLLEPFNGTEFWLDGSLTISAEEQVAFLRQVVERKLPFKASSYDSLKKVMFADENAQYRLYAKTGWATRMTPSVGWYVGYVEAKDDVWLFALNLATRDANDLPLRTQIAKDALKAIGAFPTK	32.69	gnl|BL_ORD_ID|829|hsp_num:0	901			102	177	
BGC0001307.1|Chaxapeptin_5 # 2824 # 3240 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.681	BGC0001307.1|Chaxapeptin_5 	2824	3240	+	Loose	200	24.2534	vanX gene in vanB cluster	31.03	3002950	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	GTGAGTACCCCCGCCGCCCTGGTCAAGCGCAGAAAACTGCCCTTCCATCGCAGAGTGCTGCCGCTCGTTGCTGTCGGTGTTGCCCGCCTCCTCAGCAGGACAAAGCCTGCACGGCTGCGAGCCATCCTGAGCTACGCACGACGGGGTGCCGCGCCGGCCACGGTGGAACAGGCGATGGCCGCGCGACAAGCGGTCGTCGCCGTCAGCCAACGGTGCGCCGGACAGGCCTGCCTTCAGCGTTCCATCGCGACGGCACTGCTCTGCCGGGCGCGTGGATCCTGGCCGACCTGGTGCACCGGGGTACGGACCAGCCCGTTCGAAGCCCATGCCTGGATCGAGGCCGAAGGTCGGCTCATCGGCGAGCCGTACCCGGACGGTCACTATCGGCCTTTGCTGACCGTTCCTCCGGTTTCCTGA	MSTPAALVKRRKLPFHRRVLPLVAVGVARLLSRTKPARLRAILSYARRGAAPATVEQAMAARQAVVAVSQRCAGQACLQRSIATALLCRARGSWPTWCTGVRTSPFEAHAWIEAEGRLIGEPYPDGHYRPLLTVPPVS	MENGFLFLDEMLHGVRWDAKYATWDNFTGKPVDGYEVNRIIGTKAVALALREAQIHAARLGYGLLLWDGYRPKSAVDCFLRWAAQPEDNLTKEKYYPNIERAELITKGYVASQSSHSRGSTIDLTLYHLDTGELVSMGSNFDFMDERSHHTAKGIGNAEAQNRRCLRKIMESSGFQSYRFEWWHYKLIDEPYPDTYFNFAVS	68.32	gnl|BL_ORD_ID|1647|hsp_num:0	1666			507	594	vancomycin
BGC0001307.1|Chaxapeptin_6 # 3448 # 3831 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.693	BGC0001307.1|Chaxapeptin_6 	3448	3831	-	Loose	700	23.483	oleI	28.12	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGTGCTGCGGCCGTCGCCGCCCTCGCCCTCACCCCGCTGACCGCTCCGGCCTCGGCTTCCAGCGAGCCCCATGCGGCACGGGCCGCGATCGACTGCCCGTCCGGCTACGTCTGCATCTACCCCGAGATCAACTTCGGCGGCCAGCCCTGGGTACGCCGGGCTTCCGATGGCAGCGTGAAGGACCTGCCTTCCGCGATCCGGGACCGCGGCAGCTCCATCCGCAACAACTCCGACCGCACCGCCCGCATCTACGAGAAGCGCAACCACGCCGGCCGCTGGGTGTGCGTCACCCGCAGCGGCGGATCCATCCACGACCTGCGCGGCTACAACCTCAACGATCAGACCCGCTCCCTGAAGATCAACCGGAACGACTGCGGCTGA	MRAAAVAALALTPLTAPASASSEPHAARAAIDCPSGYVCIYPEINFGGQPWVRRASDGSVKDLPSAIRDRGSSIRNNSDRTARIYEKRNHAGRWVCVTRSGGSIHDLRGYNLNDQTRSLKINRNDCG	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	29.95	gnl|BL_ORD_ID|1684|hsp_num:0	1824			648	744	oleandomycin
BGC0001307.1|Chaxapeptin_7 # 3921 # 4082 # 1 # ID=1_7;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.691	BGC0001307.1|Chaxapeptin_7 	3921	4082	+	Loose	560	23.0978	AAC(3)-IIa	35.71	3002533	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGCCTCCGCGATGCCCGGGTCCACCCGCTGCTCGGGGACGACGGCCAGGTGTGCGGCCAATGTGCGGCGGCAGCCGCCCGAATATGGCAGACCAGTCGGGGCCCAGTACCGTGGGTACGGGTACGTACCCGTACCCTGCTTGTCTGGAGGGAGCCTGATG	MASAMPGSTRCSGTTARCAANVRRQPPEYGRPVGAQYRGYGYVPVPCLSGGSLM	MHTQKAITEALQKLGVQSGDLLMVHASLKSIGPVEGGAETVVAALRSAVGPTGTVMGYASWDRSPYEETLNGARLDDNARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASMVAVGPLAETLTEPHELGHALGEGSPNERFVRLGGKALLLGAPLNSVTALHYAEAVADIPNKRWVTYEMPMPGRDGEVAWKTASDYDSNGILDCFAIEGKQDAVETIANAYVKLGRHREGVVGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPAHEAIERSCEPSG	18.88	gnl|BL_ORD_ID|430|hsp_num:0	478			216	300	dibekacin; sisomicin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
